IC₅₀ Tracking & Dose-Response Visualization Now Live in QuantumCURE Pro

Big Update:

register as a Guest, Select Entropy source, Target Protein, pick a compute method, optional Omics results, number of compounds or import yours.

I’re thrilled to announce a major upgrade to QuantumCURE Pro, coming officially in the January 15, 2026 release, but beta users can try it now by logging in with the Guest account (free access).

What’s New

We’ve added IC₅₀ (Half Maximal Inhibitory Concentration) tracking and visualization across the entire QuantumCURE Pro workflow. which bring laboratory-grade pharmacological insight into your in silico docking results.

Here’s what’s inside:

• Predicted IC₅₀ Values: Every compound now includes an estimated IC₅₀, automatically labeled by potency:

  • Extremely Potent < 10 nM

  • Highly Active 10–100 nM

  • Moderate Activity 100 nM–1 µM

  • Weak Activity > 1 µM

• Experimental IC₅₀ Integration: You can now track real-world assay data inside the Wet-List Builder, merging in vitro results with QuantumCURE’s in silico predictions.

• IC₅₀ Graphs & Curves: Expand any compound to see its dose-response curve — a clean, sigmoidal chart showing the IC₅₀ marker, confidence band, and potency classification, displayed right beside its Bemis–Murcko scaffold for structural context.

IC₅₀ Tracking & Dose-Response, Binding Affinity, Quantum Score, Glyphs, ready for export

IC₅₀ Tracking & Dose-Response and Bemis-Murcko Visualization. Export results to GraphPad Prisim

It does Matter!

This addition closes the gap between computational screening and experimental pharmacology, making QuantumCURE Pro a true “bench-to-cloud” platform. Researchers can now visualize potency, structure, and quantum-entropy-driven binding behavior all in one interface.

How to Try It

• Go to https://citizenscientist.org/

• Choose Login → Guest Account

• Load any docking result or example project and explore the new IC₅₀ views

This feature is available immediately for beta testers and will roll out to all licensed tiers in

January 2026 alongside other performance updates and SKALA integration.

✨ QuantumCURE Pro, and bridging quantum entropy, molecular docking, and real-world pharmacology.